Komori
Vital Ksk Holdings (3151) · InitiativeFirst stated

Promoting DX in Dispensing Pharmacies

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Improving Pharmacy Operations and Healthcare Quality, Including AI and Capital InvestmentA theme 5 companies write about · 0 as a headwind · 6 as a tailwind

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「3. Promoting DX in dispensing pharmacies」

    The Group has identified the promotion of DX in dispensing pharmacies as a key initiative in the pharmaceutical wholesale business under the Fifth Medium-Term Management Plan.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Promoting DX in Dispensing Pharmacies | VITAL KSK HOLDINGS,INC. (3151) | Komori